The common cold drug maker to a cure

The talking sick days get to the set tougher there money .
The common cold for a cure. The Australian maker biota
Wednesday drug the reported stunning success of its antiviral
compound named vaepndavir. the Tested in 300
asthmatic patients infected with the cold-causing
human retrovirus, the clinical trial showed that cold
symptoms eased quickly and the duration of the
 infection was shortened considerably.Patients given a placebo experienced the worst cold
 symptoms at 2.5 days, where as those dosed with
 Vapendavir began rapid recovery after just 1.7 days.